What is JBIO's investment proceeds?

JBIO (JBIO) reported investment proceeds of $65.43M in Q1 2026.

How has JBIO's investment proceeds changed year-over-year?

JBIO's investment proceeds increased by 409.2% year-over-year, from $12.85M to $65.43M.

What is the long-term trend for JBIO's investment proceeds?

Over 2 years (2022 to 2024), JBIO's investment proceeds has grown at a -30.1% compound annual growth rate (CAGR), from $154.74M to $75.71M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

JBIO JBIO Investment Proceeds

Investment Proceeds at other companies

Travere Therapeutics, Inc.TVTX

$48.78M-8.2%

AnaptysBio, Inc.ANAB

$35M-74.5%

Avalo TherapeuticsAVTX

$25.51M—

Viridian Therapeutics, Inc.VRDN

$168.6M-1.6%

AnnexonANNX

$33M-79.3%

Nektar TherapeuticsNKTR

$101.48M+46.4%

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B+318%

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's investment proceeds?: JBIO (JBIO) reported investment proceeds of $65.43M in Q1 2026.
How has JBIO's investment proceeds changed year-over-year?: JBIO's investment proceeds increased by 409.2% year-over-year, from $12.85M to $65.43M.
What is the long-term trend for JBIO's investment proceeds?: Over 2 years (2022 to 2024), JBIO's investment proceeds has grown at a -30.1% compound annual growth rate (CAGR), from $154.74M to $75.71M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.